The Yokohama Convention & Visitors Bureau Reaffirms Its Pledge to Sustainable Development
As part of Yokohama’s move to take the lead on sustainable urban development, the Yokohama Convention & Visitors Bureau (YCVB) is reaffirming the city’s sustainability ideals and commitments by creating new programs for convention organizers and participants.
These YCVB programs are designed to take sustainability from ideal concept to practical application.
Sustaining Tradition
The first of many projects is the creation of traditional Japanese wooden tearooms that are portable and can be easily erected in conference or event settings. The tearooms are constructed using miyadaiku carpentry, a traditional form of carpentry that can be seen at historic shrines, temples, and teahouses across Japan. This project is a reminder that structures made from renewable materials can sustain both the craft and its aesthetics for future generations.
The prefabricated tearooms continue an artisanal craft 1,400 years in the making—one that is inscribed on UNESCO’s Intangible Cultural Heritage list (as of 2020).
Yokohama: Blue, Green, and Much More in Between
Yokohama aspires to embody sustainability, taking advantage of its many natural attractions from the green expanses of its abundant public spaces to the blue waters of its historic harbor. These new YCVB programs reflect Yokohama and its culture, creating synergy between the city and convention planners and participants.
A short film reveals the continued importance of sustainability to the Yokohama, as a city built in harmony with the natural environment, now, and for the future.
ENDS
About Yokohama Convention & Visitors Bureau:
The role of the Yokohama Convention & Visitors Bureau (YCVB) is to make use of the wealth of resources at the disposal of the City of Yokohama and the wider Kanagawa Prefecture, and promote the region as an ideal destination for both tourists and international conventions. In doing so, the YCVB aims to reinvigorate the City of Yokohama and its surrounding areas, while driving its globalization.
Facebook: https://www.facebook.com/DISCOVERYOKOHAMA.JAPAN
Instagram: https://www.instagram.com/yokohama_visitors_guide/
YouTube: https://www.youtube.com/channel/UC3s7Mt89lyvTZVl1x5_Mr_g
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220512005046/en/
Contact information
Akiko Hosono
Yokohama Convention and Visitors Bureau
Phone: +81-45-221-2111 E-mail: mice@ycvb.or.jp
About Business Wire
Business WireSubscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AriBio Co., Ltd. to Present Biomarker Data for AR1001 from the Mild to Moderate Alzheimer’s Disease Phase 2 Study at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2023)31.3.2023 18:00:00 CEST | Press release
AriBio Co., Ltd. announced that David Greeley MD, Chief Medical Officer at AriBio, will present biomarker data from the completed phase 2 study in patients with mild to moderate Alzheimer’s disease who were treated with 10mg and 30mg of AR1001. AR1001 is a potent PDE5 inhibitor with preliminary efficacy in cognition, and preclinical effects on neuron apoptosis inhibition, promotion of neurogenesis, increase in neuroplasticity, and stimulation of autophagy to remove toxic proteins. The phase 2 study was a double-blind, randomized, placebo-controlled, multi-center trial to evaluate the safety and preliminary efficacy of AR1001 over 26 and 52 weeks of treatment in patients with mild to moderate Alzheimer’s disease. The trial enrolled 210 patients at 21 research centers in the United States. Plasma collected from patients at baseline, week 26 and week 52 was analyzed by Quantarix using the Simoa HD-X analyzer. Meaningful, statistically significant changes were found over 52 weeks of treatm
KANEKA: “Development of Polymer Synthesis Technology by Microorganisms using CO2 as Direct Raw Material” selected as a NEDO Green Innovation Fund Project”31.3.2023 16:09:00 CEST | Press release
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka; hereinafter "Kaneka"), Bacchus Bio innovation Co., Ltd (Headquarters: Kobe-city, Hyogo; President: Mikio Tanji; hereinafter "Bacchus"), JGC Holdings Corporation (Headquarters: Yokohama-city Kanagawa; Chairman and CEO: Masayuki Sato; hereinafter "JGC HD"), and Shimadzu Corporation (Headquarters: Kyoto-city, Kyoto; President: Yasunori Yamamoto; hereinafter "Shimadzu") have announced that the proposal of a joint project, “Development of Polymer Synthesis Technology by microorganisms using CO2 as direct raw material (hereinafter referred to as ‘the Project’)” had been selected by the "Green Innovation Fund Project*1 / Promotion of Carbon Recycling Using CO2 from Biomanufacturing Technology as a Direct Raw Material” as a planned implementation sponsored by the New Energy and Industrial Technology Development Organization (NEDO). This press release features multimedia. View the full release here: https://www.busine
Allianz Appoints Leadership for Allianz Commercial Key Markets31.3.2023 15:11:00 CEST | Press release
As part of the implementation of its ‘Integrated Commercial’ strategy to better serve the full Commercial segment, Allianz Group today announced the leadership for four of its largest Property and Casualty Commercial insurance markets: Australia, France, Germany and the United Kingdom. In each country, the appointed single Commercial lead will represent the integrated Allianz Commercial business and bring to the market Allianz’s full set of solutions for specialty clients, large corporates, and mid-sized companies, simplifying and enhancing the experience of clients and distribution partners. “The appointment of the regional leaders in our core Allianz Commercial markets is an important, concrete step toward realizing our new integrated model, which brings together our Mid Corporate and Large Corporate insurance business for the benefit of our clients and distribution partners,” said Chris Townsend, Member of the Allianz SE Board of Management. Townsend added, “As one face to the marke
Huawei Releases 2022 Annual Report: Steady Operations, Sustainable Survival and Development31.3.2023 11:59:00 CEST | Press release
Huawei released its 2022 Annual Report today. The company reports steady operations throughout 2022, having generated CNY642.3 billion in revenue and CNY35.6 billion in net profits. Huawei continues to strengthen investment in R&D, with an annual expenditure of CNY161.5 billion in 2022, representing 25.1% of the company's annual revenue and bringing its total R&D expenditure over the past 10 years to more than CNY977.3 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230331005166/en/ (Photo: Huawei) "In 2022, a challenging external environment and non-market factors continued to take a toll on Huawei's operations", said Eric Xu, Huawei's Rotating Chairman, at the company's annual report press conference. "In the midst of this storm, we kept racing ahead, doing everything in our power to maintain business continuity and serve our customers. We also went to great lengths to grow the harvest – generating a steady stream
Horizon Quantum Computing Raises USD 18.1 million Series A to Advance Quantum Software Development31.3.2023 09:30:00 CEST | Press release
Horizon Quantum Computing,a Singapore-based company building software development tools to unlock the potential of quantum computing hardware, announced today that it has raised USD 18.1 million Series A investment from Sequoia Capital India, Tencent, SGInnovate, Pappas Capital and Expeditions Fund. The investment round will boost the growth of the company, allowing it to strengthen its science and engineering teams to accelerate product development, establish its new engineering centre in Europe and bring Horizon’s unique technology to the market. Horizon Quantum Computing’s total funding now stands at approximately USD 21.3 million. “Quantum computing has the potential to completely change how we think about computing,” says Horizon’s CEO Dr Joe Fitzsimons. “While getting to large scale quantum computing is a daunting challenge, it is undeniable that progress towards that goal is being made. At Horizon, we focus on unlocking the power of future quantum computers, and have made signif
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom